“POSSIBILITIES OF USING RUXOLITINIB TO IMPROVE THE RESULTS OF allo-HSCT (LITERATURE REVIEW)” (2019) Voprosy onkologii, 65(3), pp. 330–336. doi:10.37469/0507-3758-2019-65-3-330-336.